Article citationsMore>>

Mcphee, L.C., Badawi, O., Fraser, G.L., et al. (2013) Single-Dose Etomidate Is Not Associated with Increased Mortality in ICU Patients with Sepsis: Analysis of a Large Electronic ICU Database. Critical Care Medicine, 41, 774-783.
https://doi.org/10.1097/CCM.0b013e318274190d

has been cited by the following article:

• TITLE: Retrospective Review of Propofol versus Etomidate during Rapid Sequence Intubation in the Emergency Department at a Tertiary Academic Center

  AUTHORS: Megan A. Rocchio, Katelyn Sylvester, Nahal Beik, Nicole M. Glasser, Paul M. Szumita

  KEYWORDS: Rapid Sequence Intubation, Etomidate, Zropofol, Safety, Efficacy

  JOURNAL NAME: Pharmacology & Pharmacy, Vol.8 No.7, July 17, 2017

  ABSTRACT: Background: Etomidate is the standard induction agent used during rapid sequence intubation (RSI) in the emergency department (ED). Etomidate shortages require providers to utilize alternative agents. The purpose of this study is to compare the safety and procedural outcomes of propofol and etomidate for RSI in the ED. Methods: This was a retrospective chart review of adult patients in the ED who received propofol or etomidate for induction during RSI. The main endpoint was hypotension, defined as a systolic blood pressure